Tennessee HOPE Treatment Act to fund ibogaine clinical trials for mental health conditions.
The Tennessee HOPE Treatment Act establishes a framework for funding and conducting clinical trials on ibogaine, a Schedule I drug, for treating mental health conditions such as opioid use disorder, PTSD, and depression. The act creates the Tennessee Mental Health Innovation Fund to allocate funds for these trials. It mandates the Department of Mental Health and Substance Abuse Services to select a cohort to conduct the trials, which must include a research institution, a drug developer, and a hospital.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.